Inhaled Steroid Growth Effect Label Should Reflect Product Data - Schering
Executive Summary
Inhaled and intranasal corticosteroid products that have demonstrated no effect on pediatric growth should be exempt from FDA's new class labeling for the asthma and allergy drugs, Schering-Plough maintained.